Trevena
TRVN
#10794
Rank
S$0.01 M
Marketcap
S$0.01406
Share price
0.00%
Change (1 day)
-99.01%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -S$41.19 Million

According to Trevena's latest financial reports the company's current earnings are S$0.54 Million. In 2023 the company made an earning of -S$46.42 Million, an increase over its 2022 earnings that were of -S$66.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$41.19 Million-11.28%
2023 -S$46.42 Million-30.69%
2022 -S$66.98 Million1.38%
2021 -S$66.07 Million78.04%
2020 -S$37.11 Million21.3%
2019 -S$30.59 Million-13.91%
2018 -S$35.54 Million-59.75%
2017 -S$88.28 Million-31.77%
2016 -S$0.13 Billion101.73%
2015 -S$64.14 Million1.14%
2014 -S$63.42 Million114.83%
2013 -S$29.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$11.61 B-29,360.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.80 B-42,449.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.07 Billion 2,571.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-S$13.15 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-S$80.24 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.81 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA